eLetters

243 e-Letters

published between 2003 and 2006

  • An excellent alternative
    Sudesh Shetty

    Dear Editor

    My experience with ketamine anaesthesia in paediatric ophthalmic surgery in a semi-rural setting is very positive. It provides a viable alternative to more expensive and infrastructure-intensive anaesthesia procedures, and is more than sufficient to complete most ophthalmic procedures.

    Reference

    (1) M S Pun, J Thakur, G Poudyal, R Gurung, S Rana, G Tabin, W V Good, and S Ruit. Ketamine...

    Show More
  • Acanthamoeba Keratitis: correct interpretation of surveillance data
    Barny G Foot

    Dear Editor

    The comment of Seal et al.[1] on the report by Radford et al.[2] on the incidence of acanthamoeba keratitis highlighted a number of points of interest when interpreting the results of a surveillance project carried out through the British Ophthalmological Surveillance Unit (BOSU).

    The correspondence describes the study as a questionnaire survey. This is incorrect; cases were asc...

    Show More
  • LASIK after scleral buckling surgery
    Alvin K. Kwok

    Dear Editor

    Sinha et al. describing ten eyes of nine patients who had a myopic refractive error and had previously undergone retinal detachment surgery underwent LASIK surgery.[1]

    All of them received a scleral buckle and encirclage at least six months before LASIK surgery. The LASIK surgery could be completed in eight eyes but in two eyes it was aborted intraoperatively because of inadequate suction se...

    Show More
  • Author's Reply
    Jorge G Arroyo

    Dear Editor

    The authors read with interest the comments made by Dr Arevalo and colleagues.[1] We certainly agree that new breaks may develop in the vitreous base region within 2 clock hours of the scleral wound. Because of this, we advocate the use of encircling scleral buckles (3.5-5 mm wide) as opposed to segmental scleral buckles in patients undergoing primary open-globe injury repair.

    We agree that...

    Show More
  • Re: Thermochemotherapy in hereditary retinoblastoma
    Santosh G Honavar, MD

    Dear Editor

    Schueler and associates describe their experience with thermochemotherapy (TCT) in bilateral retinoblastoma.[1] The reported results of transpupillary thermotherapy used in combination with chemotherapy are encouraging, with 86-96% tumor control.[2,3] In the current series, however, local recurrence occurred in 38%.

    The dosage of carboplatin used in the current series was 10 mg/Kg BW, which is lower...

    Show More
  • Response to allegations and some considerations on interferon treatment in Behcet's disease
    Haluk Demiroglu, MD

    Dear Editor

    Kotter et al. refer to some problems, such as fabrication of authorship, data and ethical transgressions,[1] in our article published in The Lancet[2] on February 19, 2000. However, they do so without knowing the current facts about an ongoing process. They cite accusations that rely on an unfinalised investigation from the year 2000. As we are now in 2003, I do feel that I have to present updated cor...

    Show More
  • Trypan blue stains the epiretinal membrane but not the internal limiting membrane
    EB Rodrigues

    Dear Editor

    We read with great interest the manuscript by Li et al. about staining of the internal limiting membrane (ILM) and epiretinal membrane (ERM) with trypan blue (TB).[1] We would like to comment one aspect of this manuscript, when the authors claimed that a good staining of both the ILM and the ERM was achieved with TB. We disagree that ILM is stained by TB, and propose that TB only stains the ERM, but...

    Show More
  • Retinopathy of prematurity as a cause of childhood blindness: The Ethiopian context.
    Dr Vasumathy Vedantham MS, DNB, FRCS (Edinburgh).

    Dear Editor

    We read with great interest the article by Kello et al.[1] on the causes of severe visual impairment and blindness in children in schools for the blind in Ethiopia. The authors have to be congratulated for the hardhitting and well written article. A current concern for people involved in pediatric eye care is the emergence of what is probably the third epidemic of retinopathy of prematurity (ROP)...

    Show More
  • Are we overlooking the side-effects of the drugs in our zeal to conquer ARMD?
    Uday K Bhatt

    Dear Editor

    First of all let me congratulate the authors for their work on exudative ARMD. But there are still some issues which need to be brought into account:

    1. Some published studies show that even 4.0 mg of intravitreal triamcinolone has significant side effects in terms of increased IOP and more so for eyes which needed the second dose of the triamcinolone, with a few of them even needing a filtratio...

    Show More
  • Authors' Reply
    Marco A Zarbin, MD, PhD
    Dear Editor

    We thank Professor McLeod for his interest in our paper, “Vitrectomy with Silicone Oil Infusion in Severe Diabetic Retinopathy”[1] and value the opportunity to address some of the issues he has raised.[2]

    Professor McLeod notes that surgical success can be judged only if the retina has remained attached for a minimum of six months from the last retinal procedure. He notes that 10 (43%) of 23 eyes in our r...

    Show More

Pages